A Bibliometric Analysis of the WoSCC Literature on the Use of Selective Serotonin Reuptake Inhibitors as Antidepressants
Jiyang Li, Xinxing Fei, Shiqi Wang, Zhangyu Xu, Fangyuan Xu, Jianxiong Wang, Yaqian Gao, Yue Hu · 2024
Read A Bibliometric Analysis of the WoSCC Literature on the Use of Selective Serotonin Reuptake Inhibitors as Antidepressants by Jiyang Li, Xinxing Fei, Shiqi Wang, Zhangyu Xu, Fangyuan Xu, Jianxiong Wang, Yaqian Gao, Yue Hu (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11545711.txt.
Description
Jiyang Li and colleagues published a bibliometric analysis in 2024. They mapped research on SSRI antidepressant drugs. SSRIs are widely used to treat depression worldwide. Thousands of studies exist, but overall trends were unclear. Little quantitative mapping of the field existed before. The team searched a major citation database thoroughly. Over one thousand publications were included in total. Papers spanned more than three decades of research. Software tools charted authors, journals, and institutions.
Yearly output rose steadily until the mid two thousands. Output then held roughly stable each year. The United States led the field by volume. One university and one author stood out strongly. A European journal published the most work there. Maps like this reveal crowded and neglected areas. New researchers can find key groups more quickly.
Catalog record
| CREATOR | Jiyang Li, Xinxing Fei, Shiqi Wang, Zhangyu Xu, Fangyuan Xu, Jianxiong Wang, Yaqian Gao, Yue Hu |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |